Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
US-2020199079-A1 · Jun 25, 2020 · US
US10214494B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10214494-B2 |
| Application number | US-201715725848-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 5, 2017 |
| Priority date | Oct 9, 2014 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Backfunctionalized imidazolinium salts and methods of synthesizing the same and NHC carbene-metal complexes therefrom. For backfunctionalized imidazolinium salts of the formula: Wherein R 1 is selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 is selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion; the method comprises cyclization of a halogenated acrylate with Hünig's base in a solvent.
Opening claim text (preview).
What is claimed is: 1. An N-heterocyclic carbene-metal complex comprising: a metal; and a first ligand coordinated to the metal and comprising a free N-heterocyclic carbene synthesized from a backfunctionalized imidazolinium salt comprising the formula: R 1 being selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 being selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; each of R 3 and R 4 being separately selected from the group consisting of a C 1 -C 20 alkyl group, C 1 -C 20 partially fluorinated alkyl group, an aryl group, an aryl group with para CF 3 functionality, an aryl group having C 1 -C 20 partially fluorinated alkyl groups or partially fluorinated alkoxy groups, and a C 1 -C 20 partially fluorinated aliphatic group, and a C 1 -C 20 aryl group; and X is an anion. 2. The N-heterocyclic carbene-metal complex of claim 1 , wherein the metal is selected from the group consisting of rhenium, ruthenium, osmium, rhodium, iridium, palladium, platinum, silver, and gold. 3. The N-heterocyclic carbene-metal complex of claim 1 , further comprising: a second ligand coordinated to the metal, the second ligand comprising another free N-heterocyclic carbene synthesized from a backfunctionalized imidazolinium salt comprising the formula: R 1 being selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 being selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; each of R 3 and R 4 being separately selected from the group consisting of a C 1 -C 20 alkyl group, C 1 -C 20 partially fluorinated alkyl group, an aryl group, an aryl group with para CF 3 functionality, an aryl group having C 1 -C 20 partially fluorinated alkyl groups or partially fluorinated alkoxy groups, and a C 1 -C 20 partially fluorinated aliphatic group, and a C 1 -C 20 aryl group; and X is an anion. 4. The N-heterocyclic carbene-metal complex of claim 3 , further comprising: a third ligand selected from the group consisting of an acetylacetonate, alkoxy, alkyl, aryl, aryloxy, carbonyl, halide, imido, oxo, pyridine, trialkylphosphine, and triarylphosphine, the third ligand being coordinated to the metal. 5. The N-heterocyclic carbene-metal complex of claim 1 , further comprising: a second ligand selected from the group consisting of an acetylacetonate, alkoxy, alkyl, aryl, aryloxy, carbonyl, halide, imido, oxo, pyridine, trialkylphosphine, and triarylphosphine, the second ligand being coordinated to the metal. 6. The free N-heterocyclic carbene of claim 2 , wherein X is a halogen anion. 7. The free N-heterocyclic carbene of claim 2 , wherein R 1 is in a trans-configuration with respect to R 2 . 8. The N-heterocyclic carbene-metal complex of claim 1 , wherein the free N-heterocyclic carbene is synthesized by deprotonation. 9. The N-heterocyclic carbene-metal complex of claim 8 , wherein deprotonation includes reacting the backfunctionalized imidazolinium salt with silver oxide. 10. The N-heterocyclic carbene-metal complex of claim 1 , wherein the free N-heterocyclic carbene is synthesized by formamidine cyclization of a halogenated acrylate with a primary base in a solve, the primary base being Hünig's base. 11. The N-heterocyclic carbene-metal complex of claim 10 , wherein the solvent is acetone and toluene.
Ruthenium compounds · CPC title
Iridium compounds · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.